EFG - ETF AI Analysis
Top Page
iShares MSCI EAFE Growth ETF (EFG)
Rating:65Neutral
Price Target:―
Positive Factors
Strong Leading Holdings
Key positions like ASML, Tokyo Electron, and several industrial names have shown strong gains, helping drive the ETF’s overall performance.
Broad International Diversification
The fund spreads its investments across many developed markets such as Japan, the UK, Europe, and Australia, reducing reliance on any single country.
Growth-Focused Exposure
A tilt toward growth-oriented sectors like technology, industrials, and health care offers potential for long-term capital appreciation.
Negative Factors
Concentration in a Few Large Positions
The largest holdings, especially ASML, make up a meaningful share of the portfolio, increasing the impact if any of these companies stumble.
Mixed Performance Among Top Holdings
Some major positions, such as AstraZeneca and SAP, have shown weak or lagging performance, which can offset gains from stronger names.
Limited U.S. Market Exposure
With only a small portion of assets in U.S. stocks, the ETF may lag broader global benchmarks when the U.S. market is leading.
EFG vs. SPDR S&P 500 ETF (SPY)
AUM17.17B
RegionDeveloped Markets
Expense Ratio0.36%
Beta0.92
IssueriShares
Inception DateAug 01, 2005
Dividend Yield2.22%
Asset ClassEquity
Index TrackedMSCI EAFE Growth
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume446,790
30 Day Avg. Volume742,861
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
152.64Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering352
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
EFG Summary
The iShares MSCI EAFE Growth ETF (EFG) is a fund that follows the MSCI EAFE Growth Index, focusing on fast-growing companies in developed markets outside the U.S. and Canada, such as Japan, the UK, and Europe. It holds well-known international names like ASML Holding and AstraZeneca, spread across sectors like technology, industrials, and finance. Investors might consider EFG to add global diversification and tap into long-term growth from overseas companies. However, its value can go up and down with global stock markets and may be especially sensitive to swings in growth-focused stocks.
How much will it cost me?The iShares MSCI EAFE Growth ETF (EFG) has an expense ratio of 0.36%, meaning you’ll pay $3.60 per year for every $1,000 invested. This cost is slightly higher than average for ETFs because it tracks a growth-focused index, which requires more active management compared to broad, passively managed funds. It’s still considered reasonable for the specialized exposure it provides.
What would affect this ETF?The iShares MSCI EAFE Growth ETF could benefit from continued innovation and expansion in technology and industrial sectors, which make up a significant portion of its holdings. However, challenges like rising interest rates or economic slowdowns in developed markets outside North America could negatively impact growth-focused companies. Additionally, regulatory changes or geopolitical tensions in regions like Europe or Asia may affect the ETF’s performance.
EFG Top 10 Holdings
EFG is leaning heavily on the global semiconductor boom, with ASML, Advantest, and Tokyo Electron acting as the fund’s main growth engines and keeping performance on an upswing. Industrial names like Schneider Electric and ABB add a steady backbone, helping smooth out volatility. On the flip side, AstraZeneca and Commonwealth Bank of Australia have been lagging, slightly dragging on returns. Overall, the ETF is tilted toward tech and industrial growth stories across Europe and Asia, giving investors broad developed-market exposure without U.S. heavyweights.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 6.05% | $1.04B | €572.06B | 126.61% | 76 Outperform | |
| AstraZeneca | 2.22% | $381.03M | $257.86B | 2.57% | 80 Outperform | |
| SAP SE | 2.07% | $354.29M | €210.18B | -19.66% | 66 Neutral | |
| Schneider Electric | 1.71% | $292.43M | €168.96B | 39.29% | 62 Neutral | |
| Commonwealth Bank of Australia | 1.68% | $287.02M | AU$259.90B | -10.32% | 64 Neutral | |
| Rolls-Royce Holdings | 1.57% | $268.22M | £128.34B | 43.12% | 71 Outperform | |
| UBS Group AG | 1.55% | $265.56M | $165.25B | 33.89% | 73 Outperform | |
| Advantest | 1.44% | $246.55M | ¥24.90T | 169.54% | 75 Outperform | |
| Tokyo Electron | 1.41% | $242.19M | ¥25.23T | 150.60% | 73 Outperform | |
| ABB Ltd | 1.39% | $237.62M | kr1.69T | 48.53% | 78 Outperform |
EFG Technical Analysis
Positive
―
Price Trends
123.22
Positive
121.42
Positive
118.08
Positive
Market Momentum
0.90
Positive
55.33
Neutral
46.31
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For EFG, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 125.33, equal to the 50-day MA of 123.22, and equal to the 200-day MA of 118.08, indicating a bullish trend. The MACD of 0.90 indicates Positive momentum. The RSI at 55.33 is Neutral, neither overbought nor oversold. The STOCH value of 46.31 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for EFG.
EFG Peer Comparison
Comparison Results
Performance Comparison
EFG
iShares MSCI EAFE Growth ETF
125.02
16.65
15.36%
IEFA
iShares Core MSCI EAFE ETF
―
―
―
EFA
iShares MSCI EAFE ETF
―
―
―
EFV
iShares MSCI EAFE Value ETF
―
―
―
ESGD
iShares ESG Aware MSCI EAFE ETF
―
―
―
FENI
Fidelity Enhanced International ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents